Foster & Motley Inc. acquired a new stake in Cabot Corporation (NYSE:CBT – Free Report) during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 13,152 shares of the specialty chemicals company’s stock, valued at approximately $1,194,000.
A number of other institutional investors have also recently made changes to their positions in the stock. BlackRock Inc. bought a new stake in shares of Cabot during the 2nd quarter valued at $633,302,000. Deutsche Bank AG bought a new position in Cabot in the second quarter worth approximately $5,033,000. Trust Co. of Vermont purchased a new stake in shares of Cabot during the second quarter valued at about $185,000. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new stake in shares of Cabot during the 2nd quarter valued at $1,321,000. Finally, Old West Investment Management LLC acquired a new stake in Cabot in the second quarter worth about $1,119,000. Hedge funds and other institutional investors own 93.18% of the company’s stock.
Insider Buying and Selling at Cabot
In related news, CEO Sean D. Keohane sold 91,923 shares of Cabot stock in a transaction dated Friday, August 7th. The stock was sold at an average price of $86.41, for a total value of $7,943,066.43. Following the completion of the transaction, the chief executive officer directly owned 404,134 shares in the company, valued at approximately $34,921,218.94. This trade represents a 18.53% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 3.08% of the company’s stock.
Analyst Ratings Changes
Check Out Our Latest Research Report on Cabot
Cabot Stock Performance
Shares of CBT opened at $85.34 on Thursday. The company has a current ratio of 1.47, a quick ratio of 0.97 and a debt-to-equity ratio of 0.48. Cabot Corporation has a 12-month low of $58.33 and a 12-month high of $94.53. The company has a 50-day moving average of $88.23 and a two-hundred day moving average of $80.75. The stock has a market cap of $4.41 billion, a P/E ratio of 24.04, a PEG ratio of 10.99 and a beta of 0.84.
Cabot (NYSE:CBT – Get Free Report) last announced its earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.66 by $0.01. The firm had revenue of $982.00 million for the quarter, compared to analyst estimates of $943.16 million. Cabot had a net margin of 5.23% and a return on equity of 20.29%. Cabot’s revenue was up 6.4% compared to the same quarter last year. During the same quarter last year, the business earned $1.90 earnings per share. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. As a group, research analysts predict that Cabot Corporation will post 6.33 EPS for the current fiscal year.
Cabot Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, September 11th. Investors of record on Friday, August 28th will be issued a $0.4725 dividend. The ex-dividend date of this dividend is Friday, August 28th. This represents a $1.89 dividend on an annualized basis and a yield of 2.2%. Cabot’s dividend payout ratio is currently 53.24%.
About Cabot
Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.
The company operates two primary segments: Reinforcement Materials and Performance Materials.
Further Reading
- Five stocks we like better than Cabot
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corporation (NYSE:CBT – Free Report).
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.
